Close Menu

NEW YORK (GenomeWeb) – Fluidigm and Visiopharm have signed a comarketing agreement to automate image analysis for imaging mass cytometry, the companies said today.

Under the agreement, Fluidigm and Visiopharm will copromote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system, MCD Viewer software, and related Maxpar antibodies and kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.